Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2 - Wikidata - thesis-toulmin - TriplyDB

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

http://www.wikidata.org/entity/Q33661906

about

Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.Potential use of recombinant human interleukin-6 in clinical oncology.The role of interleukin-6 in the human adrenal gland.Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.IL-6 increases MMP-13 expression and motility in human chondrosarcoma cells.Interleukin-6 immunoreactivity in human tumors Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.Antitumor activity of recombinant interleukin 6 in mice Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells Interleukin-6 and the acute phase response.Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma.Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity Cancer immunotherapy: potential involvement of mediators.Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells.Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.Syk/JNK/AP-1 signaling pathway mediates interleukin-6-promoted cell migration in oral squamous cell carcinoma Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA.A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.Growth modulation of freshly isolated non-Hodgkin's B-lymphoma cells induced by various cytokines and all-trans-retinoic-acid.Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea.Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation Interleukin-6 stimulates cell proliferation of rat pituitary clonal cell lines in vitro.Recombinant interleukin-6 inhibits the growth of rat mesangial cells in culture.Inhibitory effect of lipopolysaccharide-stimulated P388D1 macrophage-like cells on plasmacytoma cells.Interleukin-6 induces increased motility, cell-cell and cell-substrate dyshesion and epithelial-to-mesenchymal transformation in breast cancer cells Elevated serum levels of the soluble form of gp130, the IL-6 signal transducer, in HTLV-1 infection and no involvement of alternative splicing for its generation.Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.The in vivo anti-tumor effect of human recombinant interleukin-6.Cytokines and cancer.Influence of peri-operative immunotherapy on serum cytokines and soluble cytokine receptors in patients undergoing surgery for colorectal cancer.Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells.Involvement of Interleukin-6 in the Autocrine Stimulation of Chronic Lymphocytic Leukemia B Cells by Tumor Necrosis Factor.The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts.

P2860

Q24600562-CE5BB99E-C3B6-48FC-8464-BFA1265C66DD Q24633689-B74C7A71-FE4B-4291-B9E3-1370130EEA00 Q28196459-642DC410-735A-4B47-BFD2-59D86F9FDA3D Q30950997-472C5275-244B-40E7-9112-D9097731364F Q33497067-1BE8CE79-DFD1-403A-91B2-34E58B96A342 Q34204071-B9C24C81-8C3C-46C6-AF62-4BCE270909AD Q34224284-81FA0565-4E63-4557-A360-C353B3EEAE25 Q34285905-C878D355-6068-4B77-A5FB-A34DC9F5FF62 Q34294815-CB7C6012-202B-4199-AFBA-CDD79FF493E1 Q34719481-30527CC2-DB8E-45B6-A72B-C8DF6FCCFAEE Q35816757-EC805896-3341-46D2-BCD3-3EA64E29D1E6 Q36134783-0E6DE6F4-3366-4126-A58C-D19F337AF502 Q36233022-DBDE592B-914C-4A13-9298-9F1C7A1B508C Q36350671-41BAFA1C-602E-42F4-9C48-18F152F27E07 Q36357033-E5B05025-B31C-4062-AE90-C72A5CDADAA7 Q36559880-F77620C7-8B45-40D5-B74A-12EAA68074F9 Q36617834-F540EE9C-B3D9-4B70-B37C-6AF3E2248332 Q36627020-9C310A71-AB25-4D58-8695-1FCDE1D5E860 Q36628188-47A349EF-7443-4D86-B1ED-5F05E1AAA316 Q36838004-435CD648-9036-409D-AEEE-393700A3A2AC Q37514453-D2B9C765-5293-49ED-8DB6-F5E0B92C6E6F Q37535480-25F64E71-439F-427D-8DDA-80FA8FE2C573 Q37631238-01742270-76BF-4AF1-A8BB-EA7E0884E2E9 Q40651094-7D9AC079-596B-4916-AE23-F1E54D229150 Q40902026-D2904259-D633-47B1-9C1C-E18378CC227D Q41037998-D54FFED5-9A73-45C1-95BF-0FACEF9CEF03 Q41064397-E6E54B6A-9CA3-4D44-87C2-925BD80BBB0F Q41377480-2D834BBF-5804-456D-A939-8535E3C568BE Q41972891-CEACF41F-C466-4C44-88D0-51B54AFCF9BF Q42799921-4780B16C-59C8-4C3E-BBFD-96E9A50A41DF Q42803389-C3168C97-18C7-401C-A62D-9FB94A9F6FAB Q43811675-0011FE4C-22DB-4E64-9AFA-E91A757C624F Q44557733-C722A4CC-E297-4B05-A907-163E273EA552 Q45021124-E58E07B4-897C-47E3-BF05-DC602B1FC2B3 Q47912519-C0059470-F6AC-4B5F-8CF4-E1DC30B38FDB Q52865196-91EEB2FB-A9AD-493B-8379-19563A2464E1 Q53493928-BECB179E-ACA1-4B9D-A282-44387590A38B Q54471063-14862E58-3D6F-469D-818D-7DF0AE618F89 Q54540997-3DBFCA01-F6C4-47DC-BD0F-F1375BD4E8D3

P2860

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

http://www.wikidata.org/entity/Q33661906

description

1988 nî lūn-bûn

@nan

1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Growth inhibition of human bre ...... recombinant interferon-beta 2

@ast

Growth inhibition of human bre ...... recombinant interferon-beta 2

@en

type

label

Growth inhibition of human bre ...... recombinant interferon-beta 2

@ast

Growth inhibition of human bre ...... recombinant interferon-beta 2

@en

prefLabel

Growth inhibition of human bre ...... recombinant interferon-beta 2

@ast

Growth inhibition of human bre ...... recombinant interferon-beta 2

@en

P1433

Q33661906-282049C8-7CF4-4B67-866D-27021A6D326A

P1476

Q33661906-0A4A2A3E-94BF-4FB9-87E4-977A79A20DF5

P2093

Q33661906-661159E9-593B-4553-BDC3-2FDCD1920D18

Q33661906-CB6F9261-C837-49A4-B62D-F4AE80380EAE

Q33661906-D39DC886-D92C-4EA9-A25A-C214E06DAE70

Q33661906-F85A5ACD-6DB2-42CB-96DE-3C727F28CEBE

P2860

Q33661906-0818257A-5130-4FA1-8202-A3A7917CD453

Q33661906-1FA7E4D0-C992-467E-B03E-8B110AD021BF

Q33661906-2A5E0F30-961C-4476-B384-482CCB58FEF5

Q33661906-38B29775-FCB2-4E00-984E-3CDAAD59D30E

Q33661906-46E98ECB-BBEA-4191-9F6F-D6C8D8EF9C52

Q33661906-51BAA093-B2E1-4A8B-A9B7-9945D80556AD

Q33661906-5499D4AE-A172-419D-9E4B-E26ACDE81977

Q33661906-6BC970F9-58F6-4208-BAE3-5614CF14DCC1

Q33661906-7B804BC7-A9AE-465C-84F5-A92FA2120F7A

Q33661906-875DDFC1-2C58-4A2A-B2ED-04F49AB5B23D

P304

Q33661906-22FAD923-80FE-4C4A-B79A-849F54AABB3B

P31

Q33661906-98AC440C-F644-4A49-92D5-0A45AD84A202

P356

Q33661906-D97EF7D5-47E6-4D94-9788-75192B910EDD

P407

Q33661906-F2047ABF-DB89-401E-846C-F74F623F429E

P433

Q33661906-6A491D87-D42D-46C2-B65C-9D90FA40BC22

P478

Q33661906-BB5FDD3C-A648-48E7-8B8A-436748331310

P577

Q33661906-00F46025-D4BA-462F-8008-E03365E94902

P5875

Q33661906-44BA0CBD-B16E-4596-A0A7-0DF5705B5FE8

P698

Q33661906-743C62BE-D21B-4D7A-A2B8-14E496FF3EF9

P921

Q33661906-F7F9AFC9-6683-4C81-AEEE-A636D326C0C4

P932

Q33661906-C0C8C037-8E00-42D5-9B85-5A40E5948002

P356

PNAS.85.21.8037

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Growth inhibition of human bre ...... recombinant interferon-beta 2

@en

P2093

Chen L

http://www.w3.org/2001/XMLSchema#string

Mory Y

http://www.w3.org/2001/XMLSchema#string

Revel M

http://www.w3.org/2001/XMLSchema#string

Zilberstein A

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies

Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)

Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved.

Autocrine interferon and the suppression of the c-myc nuclear oncogene.

Autocrine interferons and interferon-beta 2.

P304

8037-8041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.21.8037

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20101162

http://www.w3.org/2001/XMLSchema#string

P698

3054878

http://www.w3.org/2001/XMLSchema#string

P921

P932

282349

http://www.w3.org/2001/XMLSchema#string